EDITORIAL
Published on 31 Mar 2020
Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
doi 10.3389/fimmu.2020.00507
- 2,486 views
- 5 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Dendritic Cell-based Immunotherapy in Solid and Haematologic Tumors
Dendritic Cell-based Immunotherapy in Solid and Haematologic Tumors
25k
Total downloads
81k
Total views and downloads
Articles
REVIEW
Published on 17 Feb 2020
Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity
doi 10.3389/fimmu.2020.00122
- 6,263 views
- 48 citations
REVIEW
Published on 10 Dec 2019
Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion
doi 10.3389/fimmu.2019.02876
- 10,832 views
- 78 citations
ORIGINAL RESEARCH
Published on 08 Nov 2019
Photodynamic Modulation of Type 1 Interferon Pathway on Melanoma Cells Promotes Dendritic Cell Activation
doi 10.3389/fimmu.2019.02614
- 4,613 views
- 36 citations
REVIEW
Published on 29 Oct 2019
Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications
doi 10.3389/fimmu.2019.02393
- 18,451 views
- 117 citations
ORIGINAL RESEARCH
Published on 09 Oct 2019
Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors
doi 10.3389/fimmu.2019.02353
- 6,216 views
- 32 citations
REVIEW
Published on 02 Oct 2019
CD137L-DCs, Potent Immune-Stimulators—History, Characteristics, and Perspectives
doi 10.3389/fimmu.2019.02216
- 5,509 views
- 26 citations
MINI REVIEW
Published on 25 Sep 2019
In situ Vaccination by Direct Dendritic Cell Inoculation: The Coming of Age of an Old Idea?
doi 10.3389/fimmu.2019.02303
- 4,105 views
- 19 citations
ORIGINAL RESEARCH
Published on 14 Aug 2019
Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response
doi 10.3389/fimmu.2019.01939
- 7,594 views
- 41 citations
ORIGINAL RESEARCH
Published on 21 May 2019
Autologous Hematopoietic Stem Cells Are a Preferred Source to Generate Dendritic Cells for Immunotherapy in Multiple Myeloma Patients
doi 10.3389/fimmu.2019.01079
- 2,660 views
- 10 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Molecular Innate Immunity
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore